Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Clinical Pharmacology and Therapeutics
|
October 16, 2021
Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World
Douglas McNair, Murray Lumpkin, Steven Kern, et al.
NPJ Vaccines
|
October 28, 2020
Navigating facilitated regulatory pathways during a disease X pandemic
Shmona Simpson, Ajoy Chakrabarti, David Robinson, et al.
Plos One
|
November 17, 2016
Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization
Vincent Ahonkhai, Samuel F Martins, Alexandre Portet, et al.
Journal of Public Health Policy
|
March 11, 2016
Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authorities
Lawrence Liberti, Alasdair Breckenridge, Jarno Hoekman, et al.
Journal of Pharmaceutical Policy and Practice
|
July 1, 2020
Integrating pharmaceutical systems strengthening in the current global health scenario: three 'uncomfortable truths'
Tamara Hafner, Marlon Banda, Jillian Kohler, et al.
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation
Duane Schulthess, Lynn G Baird, Mark Trusheim, et al.
PLOS Global Public Health
|
June 3, 2026
Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equity
Jean Christophe Rusatira, Eishita Pal, Jean Berchmans Uwimana, et al.
Plos Medicine
|
August 14, 2020
Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative
Hiiti Sillo, Aggrey Ambali, Samvel Azatyan, et al.
Globalization and Health
|
November 2, 2018
Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems
Lukas Roth, Daniel Bempong, Joseph B Babigumira, et al.
Clinical Pharmacology and Therapeutics
|
November 26, 2018
Recognizing that Evidence is Made, not Born
Robyn Lim, David K Lee, Pierre Sabourin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Clinical Pharmacology and Therapeutics
|
October 16, 2021
Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World
Douglas McNair, Murray Lumpkin, Steven Kern, et al.
NPJ Vaccines
|
October 28, 2020
Navigating facilitated regulatory pathways during a disease X pandemic
Shmona Simpson, Ajoy Chakrabarti, David Robinson, et al.
Plos One
|
November 17, 2016
Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization
Vincent Ahonkhai, Samuel F Martins, Alexandre Portet, et al.
Journal of Public Health Policy
|
March 11, 2016
Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authorities
Lawrence Liberti, Alasdair Breckenridge, Jarno Hoekman, et al.
Journal of Pharmaceutical Policy and Practice
|
July 1, 2020
Integrating pharmaceutical systems strengthening in the current global health scenario: three 'uncomfortable truths'
Tamara Hafner, Marlon Banda, Jillian Kohler, et al.
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation
Duane Schulthess, Lynn G Baird, Mark Trusheim, et al.
PLOS Global Public Health
|
June 3, 2026
Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equity
Jean Christophe Rusatira, Eishita Pal, Jean Berchmans Uwimana, et al.
Plos Medicine
|
August 14, 2020
Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative
Hiiti Sillo, Aggrey Ambali, Samvel Azatyan, et al.
Globalization and Health
|
November 2, 2018
Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems
Lukas Roth, Daniel Bempong, Joseph B Babigumira, et al.
Clinical Pharmacology and Therapeutics
|
November 26, 2018
Recognizing that Evidence is Made, not Born
Robyn Lim, David K Lee, Pierre Sabourin, et al.
Page
of 2